[tds_menu_login inline="yes" guest_tdicon="td-icon-profile" logout_tdicon="td-icon-log-out" tdc_css="eyJwaG9uZSI6eyJtYXJnaW4tcmlnaHQiOiIyMCIsIm1hcmdpbi1ib3R0b20iOiIwIiwibWFyZ2luLWxlZnQiOiI2IiwiZGlzcGxheSI6IiJ9LCJwaG9uZV9tYXhfd2lkdGgiOjc2N30=" toggle_hide="eyJwaG9uZSI6InllcyJ9" ia_space="eyJwaG9uZSI6IjAifQ==" icon_size="eyJhbGwiOjI0LCJwaG9uZSI6IjIwIn0=" avatar_size="eyJwaG9uZSI6IjIwIn0=" show_menu="yes" menu_offset_top="eyJwaG9uZSI6IjE4In0=" menu_offset_horiz="eyJhbGwiOjgsInBob25lIjoiLTMifQ==" menu_width="eyJwaG9uZSI6IjE4MCJ9" menu_horiz_align="eyJhbGwiOiJjb250ZW50LWhvcml6LWxlZnQiLCJwaG9uZSI6ImNvbnRlbnQtaG9yaXotcmlnaHQifQ==" menu_uh_padd="eyJwaG9uZSI6IjEwcHggMTVweCA4cHgifQ==" menu_gh_padd="eyJwaG9uZSI6IjEwcHggMTVweCA4cHgifQ==" menu_ul_padd="eyJwaG9uZSI6IjhweCAxNXB4In0=" menu_ul_space="eyJwaG9uZSI6IjYifQ==" menu_ulo_padd="eyJwaG9uZSI6IjhweCAxNXB4IDEwcHgifQ==" menu_gc_padd="eyJwaG9uZSI6IjhweCAxNXB4IDEwcHgifQ==" menu_bg="var(--news-hub-black)" menu_shadow_shadow_size="eyJwaG9uZSI6IjAifQ==" menu_arrow_color="rgba(0,0,0,0)" menu_uh_color="var(--news-hub-light-grey)" menu_uh_border_color="var(--news-hub-dark-grey)" menu_ul_link_color="var(--news-hub-white)" menu_ul_link_color_h="var(--news-hub-accent-hover)" menu_ul_sep_color="var(--news-hub-dark-grey)" menu_uf_txt_color="var(--news-hub-white)" menu_uf_txt_color_h="var(--news-hub-accent-hover)" menu_uf_border_color="var(--news-hub-dark-grey)" f_uh_font_size="eyJwaG9uZSI6IjEyIn0=" f_uh_font_line_height="eyJwaG9uZSI6IjEuMyJ9" f_uh_font_family="eyJwaG9uZSI6IjMyNSJ9" f_links_font_size="eyJwaG9uZSI6IjEyIn0=" f_links_font_line_height="eyJwaG9uZSI6IjEuMyJ9" f_links_font_family="eyJwaG9uZSI6IjMyNSJ9" f_uf_font_size="eyJwaG9uZSI6IjEyIn0=" f_uf_font_line_height="eyJwaG9uZSI6IjEuMyJ9" f_uf_font_family="eyJwaG9uZSI6IjMyNSJ9" f_gh_font_family="eyJwaG9uZSI6IjMyNSJ9" f_gh_font_size="eyJwaG9uZSI6IjEyIn0=" f_gh_font_line_height="eyJwaG9uZSI6IjEuMyJ9" f_btn1_font_family="eyJwaG9uZSI6IjMyNSJ9" f_btn1_font_weight="eyJwaG9uZSI6IjcwMCJ9" f_btn1_font_transform="eyJwaG9uZSI6InVwcGVyY2FzZSJ9" f_btn2_font_weight="eyJwaG9uZSI6IjcwMCJ9" f_btn2_font_transform="eyJwaG9uZSI6InVwcGVyY2FzZSJ9" f_btn2_font_family="eyJwaG9uZSI6IjMyNSJ9"]
15.1 C
New York
[tds_menu_login guest_tdicon="td-icon-profile" logout_tdicon="td-icon-log-out" tdc_css="eyJhbGwiOnsibWFyZ2luLWJvdHRvbSI6IjAiLCJkaXNwbGF5IjoiIn19" toggle_txt_color="var(--news-hub-white)" menu_offset_top="eyJhbGwiOiIxOSIsImxhbmRzY2FwZSI6IjE3IiwicG9ydHJhaXQiOiIxNSJ9" menu_offset_horiz="eyJhbGwiOi02LCJsYW5kc2NhcGUiOiItMyIsInBvcnRyYWl0IjoiLTIifQ==" menu_horiz_align="content-horiz-right" menu_bg="var(--news-hub-black)" menu_uh_color="var(--news-hub-light-grey)" menu_uh_border_color="var(--news-hub-dark-grey)" menu_ul_link_color="#ffffff" menu_ul_link_color_h="var(--news-hub-accent-hover)" menu_ul_sep_color="var(--news-hub-dark-grey)" menu_uf_txt_color="var(--news-hub-white)" menu_uf_txt_color_h="var(--news-hub-accent-hover)" menu_uf_border_color="var(--news-hub-dark-grey)" f_uh_font_family="325" f_uh_font_line_height="1.3" f_links_font_family="325" f_links_font_line_height="1.3" f_uf_font_line_height="1.3" f_uf_font_family="325" menu_uh_padd="eyJhbGwiOiIyMHB4IDI1cHggMThweCIsImxhbmRzY2FwZSI6IjE1cHggMjBweCAxM3B4IiwicG9ydHJhaXQiOiIxMHB4IDE1cHggOHB4In0=" menu_ul_padd="eyJhbGwiOiIxOHB4IDI1cHgiLCJsYW5kc2NhcGUiOiIxNnB4IDIwcHgiLCJwb3J0cmFpdCI6IjhweCAxNXB4In0=" menu_ul_space="eyJhbGwiOiIxMCIsImxhbmRzY2FwZSI6IjgiLCJwb3J0cmFpdCI6IjYifQ==" menu_ulo_padd="eyJhbGwiOiIxOHB4IDI1cHggMjBweCIsImxhbmRzY2FwZSI6IjEzcHggMjBweCAxNXB4IiwicG9ydHJhaXQiOiI4cHggMTVweCAxMHB4In0=" menu_shadow_shadow_size="0" menu_arrow_color="rgba(255,255,255,0)" menu_width="eyJhbGwiOiIyMjAiLCJwb3J0cmFpdCI6IjE4MCJ9" show_version="" menu_gh_padd="eyJhbGwiOiIyMHB4IDI1cHggMThweCIsImxhbmRzY2FwZSI6IjE1cHggMjBweCAxM3B4IiwicG9ydHJhaXQiOiIxMHB4IDE1cHggOHB4In0=" menu_gc_padd="eyJhbGwiOiIxOHB4IDI1cHggMjBweCIsImxhbmRzY2FwZSI6IjEzcHggMjBweCAxNXB4IiwicG9ydHJhaXQiOiI4cHggMTVweCAxMHB4In0=" menu_gh_color="var(--news-hub-light-grey)" menu_gh_border_color="var(--news-hub-dark-grey)" f_gh_font_family="325" menu_gc_btn1_bg_color="var(--news-hub-accent)" menu_gc_btn1_bg_color_h="var(--news-hub-accent-hover)" menu_gc_btn2_color="var(--news-hub-accent)" menu_gc_btn2_color_h="var(--news-hub-accent-hover)" f_btn1_font_family="325" f_btn1_font_transform="uppercase" f_btn2_font_family="325" f_btn2_font_transform="uppercase" f_btn1_font_weight="700" f_btn2_font_weight="700" show_menu="yes" f_uf_font_size="eyJsYW5kc2NhcGUiOiIxMiIsInBvcnRyYWl0IjoiMTIifQ==" icon_color="var(--news-hub-white)" icon_size="eyJhbGwiOjIyLCJsYW5kc2NhcGUiOiIyMCIsInBvcnRyYWl0IjoiMTgifQ==" avatar_size="eyJhbGwiOiIyMiIsImxhbmRzY2FwZSI6IjIwIiwicG9ydHJhaXQiOiIxOCJ9" ia_space="eyJhbGwiOiIxMCIsImxhbmRzY2FwZSI6IjgiLCJwb3J0cmFpdCI6IjYifQ==" f_toggle_font_family="325" f_toggle_font_size="eyJhbGwiOiIxNCIsImxhbmRzY2FwZSI6IjEzIiwicG9ydHJhaXQiOiIxMiJ9" logout_size="eyJhbGwiOjE0LCJsYW5kc2NhcGUiOiIxMyJ9" f_uh_font_size="eyJsYW5kc2NhcGUiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ==" f_links_font_size="eyJsYW5kc2NhcGUiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ==" f_gh_font_size="eyJsYW5kc2NhcGUiOiIxMyIsInBvcnRyYWl0IjoiMTIifQ=="]
Deals

Anker’s clone of OG AirPods just returned to $21 with several colors to choose from (30% off)

9to5Toys.com - 0
Anker Soundcore K20i Semi-in-Ear Earbuds Buy for $21 (Reg. $30) Clip the on-page 30% off coupon What we love Truth be told, I picked up a pair of these the last time they went on sale and I’ve been quite impressed with them. My tak...
Deals

Anker’s new 30W 10,000mAh Zolo MagSafe power bank with USB-C cable hits $29 Amazon low

9to5Toys.com - 0
Prime members can head to the official Anker Amazon storefront to score its new 10,000mAh Zolo Magnetic Power Bank for $28.99 shipped. That’s $11 less than what folks without a Prime membership will have to fork over for this brand-new battery pack tha...
Deals

Score UGREEN’s travel-ready MagSafe mount at $14 Prime shipped (Reg. $20)

9to5Toys.com - 0
UGREEN MagSafe Airplane Tray Mount Buy for $14 (Reg. $20) What we love With this MagSafe mount from UGREEN, you’ll no longer need to find a creative way to prop up your iPhone while on a plane. It clips onto the tray found on all majo...
Deals

Score UGREEN’s travel-ready MagSafe mount at $14 Prime shipped (Reg. $20)

9to5Toys.com - 0
UGREEN MagSafe Airplane Tray Mount Buy for $14 (Reg. $20) What we love With this MagSafe mount from UGREEN, you’ll no longer need to find a creative way to prop up your iPhone while on a plane. It clips onto the tray found on all majo...

This 6-in-1 dual 20W USB-C surge protector from Baseus just plunged to $18 (Reg. $46)

Apple’s M3 MacBook Pro with 16GB RAM/1TB SSD sees massive $600 price drop via Amazon at $1,399, more

Metal Slug Tactics gives turn-based strategy a hyper-stylized shot of adrenaline

Metal Slug Tactics gives turn-based strategy a hyper-stylized shot of adrenaline

The Legend of Heroes: Trails Through Daybreak II Preview – The Return of Arkride Solutions Office

Level up iPhone 16 photos with this 67-inch collapsible tripod and selfie stick at $15.50 (Save 61%)

Level up iPhone 16 photos with this 67-inch collapsible tripod and selfie stick at $15.50 (Save 61%)

Score $150 off OnePlus 12 and a FREE set of $180 OnePlus Buds Pro 3 at $650 today

SpaceX’s Second Gen Starship’s First Test Hints At Major Fuel Capacity Upgrade

UGREEN early Black Friday sale now live with up to 47% off Qi2 MagSafe gear, power banks, bundle deals, more

Intel Panther Lake-H CPUs Reportedly Eyeing CES 2026 Launch, Desktop & “MOP” Variants Under Consideration

A Galaxy A-Series Model Was Used To Boot Up macOS High Sierra Using Emulation, Making It An Exceptionally Impressive Feat

Apple’s originally $1,199 M2 MacBook Air with 16GB of RAM is now down at $799 shipped

PlayStation 5 Pro Unboxing – A Brief Glimpse at Sony’s Flagship Upgrade

PlayStation 5 Pro Runs Final Fantasy VII Rebirth Like a Dream, Improves Black Myth: Wukong Image Quality, New Footage Confirms

Samsung’s Galaxy Watch 7 with LTE connectivity hits $300 Amazon low today, more up to $167 off

Logitech’s new G309 LIGHTSPEED wireless gaming mouse is down to $70 today

Bloodborne Can Run At 4K Resolution, 100 FPS on an RTX 4070 With ShadPS4 Emulator Latest Version

First Amazon price drops on the new M4 Mac mini now live, but you might be better off at Best Buy

Nintendo Switch 2 is Unlikely To Be Revealed Before the End of the Year

News

Will GLP-1 Weight Loss Drugs Allow Airlines to Save Millions of Dollars and Tank the Fast Food Industry? Here are the Numbers So Far

Wccftech.com - 0
GLP-1 weight loss drugs and the ongoing advances in the AI sphere are currently two of the biggest thematic plays that Wall Street is relentlessly championing, facilitating a phenomenal influx of capital in companies that are seen as beneficiaries of the upheaval that the proponents of these nascent technologies argue is just around the proverbial corner. Recently, GLP-1 drugs from the likes of Novo Nordisk (NVO) and Eli Lilly and Company (LLY) have been billed as a blessing in disguise for the airline industry and a harbinger of doom for the fast food sector. Can a single drug really induce […]
Read more
News

GLP-1 Drug War: Obese Patients Are Typically Twice as Likely To Lose 15% Or More of Their Body Weight With Eli Lilly and Company’s...

Wccftech.com - 0
With around $100 billion in annual sales by the end of this decade up for grabs, the GLP-1 drug war for the global waistline is heating up. Around two weeks back, Novo Nordisk created a media spectacle out of a study that claimed its GLP-1 weight loss drug could slash death risk from heart disease by up to 20 percent. This salvo was apparently fired in response to the steeply discounted price at which Eli Lilly and Company began marketing its own GLP-1 drug. Well, today, the American pharma giant is again attacking Novo Nordisk's proverbial front lines, resplendent in […]
Read more
News

Broadside Against Eli Lilly and Company: Novo Nordisk Hypes the 20% Reduction in Death Risk Offered by Its GLP-1 Weight Loss Drug

Wccftech.com - 0
A price war waged by big pharma usually works in the favor of consumers, in the short term at least, or until the victor captures the market and establishes a monopoly. Eli Lilly and Company unveiled its opening gambit earlier this week by pricing its GLP-1 weight loss drug at a substantial discount to a competing offering by Novo Nordisk. The Danish pharmaceutical giant has now responded by hyping up the results of a critical trial. Glucagon-Like Peptide-1, or GLP-1 for short, plays an important role in regulating hunger. This hormone forms the bedrock of Novo Nordisk's Ozempic and Wegovy […]
Read more
News

Eli Lilly and Company’s Weight Loss Drug Zepbound Approved by FDA; Will Be Available at $1,060 Per 6 Doses

Wccftech.com - 0
The GLP-1 phenomenon is truly on the role, particularly in the US. Now, Eli Lilly and Company has moved one step closer to realizing the $100 billion annual sales potential for GLP-1 drugs by winning a key FDA approval. Eli Lilly and Company's Mounjaro (Tirzepatide) injections treat type-2 diabetes as well as obesity by targeting two hormones – Glucagon-Like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP) – to control blood sugar levels. Retatutide, another offering by Eli Lilly and Company, is currently undergoing clinical trials and supposedly offers superior results by targeting three different hunger-regulating hormones: GLP-1, GIP, and Glucagon. As […]
Read more
News

Wall Street is Downgrading Fitness Stocks Such as Peloton and Mooning Over GLP-1 Drug Makers Such as Eli Lilly and Company (LLY)

Wccftech.com - 0
The stock market is currently undergoing a thematic shift, one that favors weight loss drug manufacturers such as Eli Lilly and Company (LLY) over fitness-related names such as Peloton (PTON). Akin to a stone rolling down a hill, gathering momentum with each turn, such shifts represent generational wealth-making opportunities on the back of accelerating trends, as was witnessed when Netflix ushered in the age of content streaming or when Tesla popularized EVs as a crucial ingredient in combatting climate change. Eli Lilly and Company (LLY) Vs. Peloton (PTON) Eli Lilly and Company's Mounjaro injections treat type-2 diabetes as well as […]
Read more
News

GLP-1 Effect: Eli Lilly and Company (LLY) Smashes Q3 2023 Revenue Expectations on Weight Loss Drug Tailwind

Wccftech.com - 0
The GLP-1 mania is in full swing now, as evidenced by Eli Lilly and Company (NYSE: LLY) smashing consensus expectations for its top-line and bottom-line metrics in Q3 2023, aided by the soaring demand for its Mounjaro weight loss drug. Eli Lilly and Co...
Read more
News

As the Quest for a Miracle Weight-Loss Drug Continues, Eli Lilly and Company Seems to Have an Edge Over Novo Nordisk’s Ozempic

Wccftech.com - 0

Americans are among the least healthy first-world citizens, partly due to the fact that over 42 percent of the adults in the US suffer from obesity – a condition that […]

Written by Rohail Saleem
Read more

Tag: Eli Lilly and Company

Will GLP-1 Weight Loss Drugs Allow Airlines to Save Millions of Dollars and Tank the Fast Food Industry? Here are the Numbers So Far

News
GLP-1 weight loss drugs and the ongoing advances in the AI sphere are currently two of the biggest thematic plays that Wall Street is relentlessly championing, facilitating a phenomenal influx of capital in companies that are seen as beneficiaries of the upheaval that the proponents of these nascent technologies argue is just around the proverbial corner. Recently, GLP-1 drugs from the likes of Novo Nordisk (NVO) and Eli Lilly and Company (LLY) have been billed as a blessing in disguise for the airline industry and a harbinger of doom for the fast food sector. Can a single drug really induce […]

GLP-1 Drug War: Obese Patients Are Typically Twice as Likely To Lose 15% Or More of Their Body Weight With Eli Lilly and Company’s...

News
With around $100 billion in annual sales by the end of this decade up for grabs, the GLP-1 drug war for the global waistline is heating up. Around two weeks back, Novo Nordisk created a media spectacle out of a study that claimed its GLP-1 weight loss drug could slash death risk from heart disease by up to 20 percent. This salvo was apparently fired in response to the steeply discounted price at which Eli Lilly and Company began marketing its own GLP-1 drug. Well, today, the American pharma giant is again attacking Novo Nordisk's proverbial front lines, resplendent in […]

Broadside Against Eli Lilly and Company: Novo Nordisk Hypes the 20% Reduction in Death Risk Offered by Its GLP-1 Weight Loss Drug

News
A price war waged by big pharma usually works in the favor of consumers, in the short term at least, or until the victor captures the market and establishes a monopoly. Eli Lilly and Company unveiled its opening gambit earlier this week by pricing its GLP-1 weight loss drug at a substantial discount to a competing offering by Novo Nordisk. The Danish pharmaceutical giant has now responded by hyping up the results of a critical trial. Glucagon-Like Peptide-1, or GLP-1 for short, plays an important role in regulating hunger. This hormone forms the bedrock of Novo Nordisk's Ozempic and Wegovy […]

Eli Lilly and Company’s Weight Loss Drug Zepbound Approved by FDA; Will Be Available at $1,060 Per 6 Doses

News
The GLP-1 phenomenon is truly on the role, particularly in the US. Now, Eli Lilly and Company has moved one step closer to realizing the $100 billion annual sales potential for GLP-1 drugs by winning a key FDA approval. Eli Lilly and Company's Mounjaro (Tirzepatide) injections treat type-2 diabetes as well as obesity by targeting two hormones – Glucagon-Like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP) – to control blood sugar levels. Retatutide, another offering by Eli Lilly and Company, is currently undergoing clinical trials and supposedly offers superior results by targeting three different hunger-regulating hormones: GLP-1, GIP, and Glucagon. As […]

Wall Street is Downgrading Fitness Stocks Such as Peloton and Mooning Over GLP-1 Drug Makers Such as Eli Lilly and Company (LLY)

News
The stock market is currently undergoing a thematic shift, one that favors weight loss drug manufacturers such as Eli Lilly and Company (LLY) over fitness-related names such as Peloton (PTON). Akin to a stone rolling down a hill, gathering momentum with each turn, such shifts represent generational wealth-making opportunities on the back of accelerating trends, as was witnessed when Netflix ushered in the age of content streaming or when Tesla popularized EVs as a crucial ingredient in combatting climate change. Eli Lilly and Company (LLY) Vs. Peloton (PTON) Eli Lilly and Company's Mounjaro injections treat type-2 diabetes as well as […]

GLP-1 Effect: Eli Lilly and Company (LLY) Smashes Q3 2023 Revenue Expectations on Weight Loss Drug Tailwind

News
The GLP-1 mania is in full swing now, as evidenced by Eli Lilly and Company (NYSE: LLY) smashing consensus expectations for its top-line and bottom-line metrics in Q3 2023, aided by the soaring demand for its Mounjaro weight loss drug. Eli Lilly and Co...

As the Quest for a Miracle Weight-Loss Drug Continues, Eli Lilly and Company Seems to Have an Edge Over Novo Nordisk’s Ozempic

News

Americans are among the least healthy first-world citizens, partly due to the fact that over 42 percent of the adults in the US suffer from obesity – a condition that […]

Written by Rohail Saleem
12Page 2 of 2

Recent articles

spot_img

©Patti.tech 2022